Samantha A. Seaward

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

Maura L. Gillison, Andy Trotti, Jonathan Harris et al. · The Lancet · 2018 · 1.3K citations

Medicine, Oncology, Radiation Oncology +6

Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer

W. Robert Lee, James J. Dignam, Mahul B. Amin et al. · Journal of Clinical Oncology · 2016 · 629 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial

Alan Pollack, Theodore Karrison, Alexander G. Balogh et al. · The Lancet · 2022 · 251 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Short Term Androgen Deprivation Therapy Without or With Pelvic Lymph Node Treatment Added to Prostate Bed Only Salvage Radiotherapy: The NRG Oncology/RTOG 0534 SPPORT Trial

Alan Pollack, Theodore Karrison, Alex Balogh et al. · International Journal of Radiation Oncology*Biology*Physics · 2018 · 152 citations

Medicine, Oncology, Radiation Oncology +16